tirzepatide fda approval for weight loss Breaking News: Approves Treating Obesity FDA approves Lilly's Zepbound (tirzepatide)

Targeting METTL3 mitigates venetoclax resistance via proteasome-mediated modulation of MCL1 in acute myeloid leukemia

Here's what typically makes someone eligible: BMI Requirements Primary eligibility usually requires: BMI of 30 or higher (classified as obesity), OR BMI of 27 or higher with at least one weight-related health condition Your BMI is calculated using your height and weight, but it's important to remember that BMI doesn't tell the whole story about your health

"This is a positive step forward to making GLP-1 agonist medications more accessible and affordable," Billingsley told Fox News Digital via email

They are solely intended to help maintain & support a healthy lifestyle